2022 Q4 Form 10-Q Financial Statement
#000165495422015264 Filed on November 14, 2022
Income Statement
Concept | 2022 Q4 | 2022 Q3 | 2022 Q2 |
---|---|---|---|
Revenue | $1.124M | $352.3K | $357.8K |
YoY Change | 158.98% | -9.76% | -23.87% |
Cost Of Revenue | $371.6K | $216.8K | $208.1K |
YoY Change | -41.87% | 56.42% | -36.94% |
Gross Profit | $752.1K | $135.5K | $149.7K |
YoY Change | -466.14% | -46.2% | 6.94% |
Gross Profit Margin | 66.93% | 38.45% | 41.84% |
Selling, General & Admin | $1.380M | $975.0K | $1.361M |
YoY Change | 137.23% | 16.53% | 147.37% |
% of Gross Profit | 183.42% | 719.78% | 908.77% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $124.8K | ||
YoY Change | |||
% of Gross Profit | 16.6% | ||
Operating Expenses | $1.380M | $1.124M | $1.361M |
YoY Change | 137.23% | 34.3% | 147.37% |
Operating Profit | -$627.4K | -$988.2K | -$1.211M |
YoY Change | -20.27% | 68.96% | 195.32% |
Interest Expense | $11.12K | $2.739K | $8.780K |
YoY Change | -48.04% | -69.83% | -12.2% |
% of Operating Profit | |||
Other Income/Expense, Net | $30.34K | $0.00 | -$28.20K |
YoY Change | -100.0% | ||
Pretax Income | -$1.251M | -$969.7K | -$1.265M |
YoY Change | 63.46% | 68.41% | 216.13% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$1.309M | -$969.7K | -$1.265M |
YoY Change | 71.31% | 68.41% | 212.77% |
Net Earnings / Revenue | -116.5% | -275.25% | -353.4% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$0.26 | -$295.2K | -$247.5K |
COMMON SHARES | |||
Basic Shares Outstanding | 5.110M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q4 | 2022 Q3 | 2022 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $6.701M | $11.62M | $424.7K |
YoY Change | 291.81% | 2405.96% | |
Cash & Equivalents | $6.701M | $11.62M | $424.7K |
Short-Term Investments | |||
Other Short-Term Assets | $212.2K | $280.0K | $211.4K |
YoY Change | 32.79% | 1063.32% | |
Inventory | $105.1K | $94.34K | $108.2K |
Prepaid Expenses | |||
Receivables | $137.6K | $19.12K | $37.65K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $7.156M | $12.01M | $782.0K |
YoY Change | 260.85% | 2153.4% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | $4.209M | ||
YoY Change | |||
Intangibles | $3.865M | ||
YoY Change | 178.38% | ||
Long-Term Investments | $434.3K | $442.4K | $439.2K |
YoY Change | 3.96% | 9.59% | |
Other Assets | $111.7K | $128.6K | $138.8K |
YoY Change | 118.63% | 192.8% | |
Total Long-Term Assets | $8.620M | $1.879M | $1.886M |
YoY Change | 364.14% | 2.36% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $7.156M | $12.01M | $782.0K |
Total Long-Term Assets | $8.620M | $1.879M | $1.886M |
Total Assets | $15.78M | $13.89M | $2.668M |
YoY Change | 310.8% | 486.29% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $550.5K | $261.7K | $295.2K |
YoY Change | 147.35% | 103.82% | |
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $68.96K | $13.29K | $41.36K |
YoY Change | 141.88% | -75.69% | |
Long-Term Debt Due | $2.456M | $17.32K | $17.32K |
YoY Change | 14081.99% | -53.59% | |
Total Short-Term Liabilities | $3.303M | $350.1K | $620.2K |
YoY Change | 960.61% | 6.45% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $3.303M | $350.1K | $620.2K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $3.303M | $350.1K | $620.2K |
YoY Change | 608.18% | -30.01% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$7.580M | -$6.271M | |
YoY Change | 140.58% | ||
Common Stock | $418.2K | $418.2K | |
YoY Change | 3631.02% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $12.47M | $13.54M | $2.048M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $15.78M | $13.89M | $2.668M |
YoY Change | 310.8% | 486.29% |
Cashflow Statement
Concept | 2022 Q4 | 2022 Q3 | 2022 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.309M | -$969.7K | -$1.265M |
YoY Change | 71.31% | 68.41% | 212.77% |
Depreciation, Depletion And Amortization | $124.8K | ||
YoY Change | |||
Cash From Operating Activities | -$497.3K | -$800.5K | -$1.031M |
YoY Change | -26.93% | 80.62% | 836.99% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $0.00 | |
YoY Change | -100.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$4.306M | $0.00 | $45.69K |
YoY Change | -692.01% | -100.0% | -49.23% |
Cash From Investing Activities | -$4.306M | $0.00 | $45.69K |
YoY Change | 7511.19% | -100.0% | -49.23% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -146.1K | 11.99M | 179.2K |
YoY Change | -107.36% | 1648.31% | -50.23% |
NET CHANGE | |||
Cash From Operating Activities | -497.3K | -800.5K | -1.031M |
Cash From Investing Activities | -4.306M | 0.000 | 45.69K |
Cash From Financing Activities | -146.1K | 11.99M | 179.2K |
Net Change In Cash | -4.950M | 11.19M | -805.8K |
YoY Change | -497.0% | 4459.25% | -337.01% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$497.3K | -$800.5K | -$1.031M |
Capital Expenditures | $0.00 | $0.00 | |
Free Cash Flow | -$497.3K | -$1.031M | |
YoY Change | -580.88% | 836.99% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001825452 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
CY2022Q3 | us-gaap |
Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
|
17323 | usd |
onfo |
Stock Based Compensation Shares
StockBasedCompensationShares
|
17241 | shares | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-41466 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
ONFOLIO HOLDINGS, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
37-1978697 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1007 North Orange Street, 4th Floor | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Wilmington | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
DE | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
19801 | ||
dei |
City Area Code
CityAreaCode
|
682 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
990-6920 | ||
dei |
Security12b Title
Security12bTitle
|
Common stock, $0.001 par value | ||
dei |
Trading Symbol
TradingSymbol
|
ONFO | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2022Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
5110195 | shares |
CY2022Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
11615383 | usd |
CY2021Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
1710318 | usd |
CY2022Q3 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
19115 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
14624 | usd |
CY2022Q3 | us-gaap |
Inventory Net
InventoryNet
|
94339 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
98397 | usd |
CY2022Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
280005 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
159791 | usd |
CY2022Q3 | us-gaap |
Assets Current
AssetsCurrent
|
12008842 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1983130 | usd |
CY2022Q3 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
1308260 | usd |
CY2021Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
1388260 | usd |
CY2022Q3 | us-gaap |
Due From Related Parties
DueFromRelatedParties
|
128567 | usd |
CY2021Q4 | us-gaap |
Due From Related Parties
DueFromRelatedParties
|
51095 | usd |
CY2022Q3 | onfo |
Investment In Unconsolidated Joint Ventures Cost Method
InvestmentInUnconsolidatedJointVenturesCostMethod
|
160901 | usd |
CY2021Q4 | onfo |
Investment In Unconsolidated Joint Ventures Cost Method
InvestmentInUnconsolidatedJointVenturesCostMethod
|
138401 | usd |
CY2022Q3 | onfo |
Investment In Unconsolidated Joint Ventures Equity Method
InvestmentInUnconsolidatedJointVenturesEquityMethod
|
281523 | usd |
CY2021Q4 | onfo |
Investment In Unconsolidated Joint Ventures Equity Method
InvestmentInUnconsolidatedJointVenturesEquityMethod
|
279382 | usd |
CY2022Q3 | us-gaap |
Assets
Assets
|
13888093 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
3840268 | usd |
CY2022Q3 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
261706 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
222543 | usd |
CY2022Q3 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
47539 | usd |
CY2021Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
1498 | usd |
CY2022Q3 | onfo |
Due To Joint Ventures
DueToJointVentures
|
16 | usd |
CY2021Q4 | onfo |
Due To Joint Ventures
DueToJointVentures
|
9105 | usd |
CY2022Q3 | onfo |
Acquisition Notes Payable Current
AcquisitionNotesPayableCurrent
|
17323 | usd |
CY2021Q4 | onfo |
Acquisition Notes Payable Current
AcquisitionNotesPayableCurrent
|
17323 | usd |
CY2022Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
13286 | usd |
CY2021Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
28514 | usd |
CY2022Q3 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
480 | usd |
CY2022Q3 | us-gaap |
Deferred Revenue
DeferredRevenue
|
10198 | usd |
CY2021Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
32000 | usd |
CY2022Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
350068 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
311463 | usd |
CY2022Q3 | onfo |
Due To Joint Ventures Long Term Non Current
DueToJointVenturesLongTermNonCurrent
|
0 | usd |
CY2021Q4 | onfo |
Due To Joint Ventures Long Term Non Current
DueToJointVenturesLongTermNonCurrent
|
155000 | usd |
CY2022Q3 | us-gaap |
Liabilities
Liabilities
|
350068 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
466463 | usd |
CY2022Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | usd |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | usd |
CY2022Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
5110 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
11208 | usd |
CY2022Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
19804134 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
6513528 | usd |
CY2022Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-6271289 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3150988 | usd |
CY2022Q3 | us-gaap |
Insurance Services Revenue
InsuranceServicesRevenue
|
80771 | usd |
CY2021Q3 | us-gaap |
Insurance Services Revenue
InsuranceServicesRevenue
|
122177 | usd |
us-gaap |
Insurance Services Revenue
InsuranceServicesRevenue
|
325685 | usd | |
us-gaap |
Insurance Services Revenue
InsuranceServicesRevenue
|
405019 | usd | |
CY2022Q3 | us-gaap |
Sales Type Lease Revenue
SalesTypeLeaseRevenue
|
271530 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13538025 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3373805 | usd |
CY2022Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
13888093 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3840268 | usd |
CY2021Q3 | us-gaap |
Sales Type Lease Revenue
SalesTypeLeaseRevenue
|
268246 | usd |
us-gaap |
Sales Type Lease Revenue
SalesTypeLeaseRevenue
|
770361 | usd | |
us-gaap |
Sales Type Lease Revenue
SalesTypeLeaseRevenue
|
969604 | usd | |
CY2022Q3 | us-gaap |
Revenues
Revenues
|
352301 | usd |
CY2021Q3 | us-gaap |
Revenues
Revenues
|
390423 | usd |
us-gaap |
Revenues
Revenues
|
1096046 | usd | |
us-gaap |
Revenues
Revenues
|
1374623 | usd | |
CY2022Q3 | onfo |
Cost Of Revenue Services
CostOfRevenueServices
|
101462 | usd |
CY2021Q3 | onfo |
Cost Of Revenue Services
CostOfRevenueServices
|
148790 | usd |
onfo |
Cost Of Revenue Services
CostOfRevenueServices
|
285216 | usd | |
onfo |
Cost Of Revenue Services
CostOfRevenueServices
|
388088 | usd | |
CY2022Q3 | onfo |
Cost Of Revenue Product Sales
CostOfRevenueProductSales
|
115382 | usd |
CY2021Q3 | onfo |
Cost Of Revenue Product Sales
CostOfRevenueProductSales
|
103217 | usd |
onfo |
Cost Of Revenue Product Sales
CostOfRevenueProductSales
|
364510 | usd | |
onfo |
Cost Of Revenue Product Sales
CostOfRevenueProductSales
|
423444 | usd | |
CY2022Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
216844 | usd |
CY2021Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
252007 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
649726 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
811532 | usd | |
CY2022Q3 | us-gaap |
Gross Profit
GrossProfit
|
135457 | usd |
CY2021Q3 | us-gaap |
Gross Profit
GrossProfit
|
138416 | usd |
us-gaap |
Gross Profit
GrossProfit
|
446320 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
563091 | usd | |
CY2022Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
974998 | usd |
CY2021Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
683829 | usd |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2804151 | usd | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1659612 | usd | |
CY2022Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
148649 | usd |
CY2021Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
33473 | usd |
us-gaap |
Professional Fees
ProfessionalFees
|
598100 | usd | |
us-gaap |
Professional Fees
ProfessionalFees
|
68848 | usd | |
CY2022Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1123647 | usd |
CY2021Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
717302 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
3402251 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
1728460 | usd | |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-988190 | usd |
CY2021Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-578886 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2955931 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1165369 | usd | |
CY2022Q3 | onfo |
Equity Method Income
EquityMethodIncome
|
9568 | usd |
CY2021Q3 | onfo |
Equity Method Income
EquityMethodIncome
|
12603 | usd |
onfo |
Equity Method Income
EquityMethodIncome
|
26056 | usd | |
onfo |
Equity Method Income
EquityMethodIncome
|
40127 | usd | |
CY2022Q3 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
574 | usd |
CY2021Q3 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
1091 | usd |
us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
2292 | usd | |
us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
4036 | usd | |
CY2022Q3 | us-gaap |
Interest Expense
InterestExpense
|
2739 | usd |
CY2021Q3 | us-gaap |
Interest Expense
InterestExpense
|
10580 | usd |
us-gaap |
Interest Expense
InterestExpense
|
3995 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
14719 | usd | |
CY2022Q3 | us-gaap |
Other Income
OtherIncome
|
11091 | usd |
CY2021Q3 | us-gaap |
Other Income
OtherIncome
|
0 | usd |
us-gaap |
Other Income
OtherIncome
|
12445 | usd | |
us-gaap |
Other Income
OtherIncome
|
0 | usd | |
CY2022Q3 | us-gaap |
Other Expenses
OtherExpenses
|
0 | usd |
us-gaap |
Other Expenses
OtherExpenses
|
29557 | usd | |
us-gaap |
Other Expenses
OtherExpenses
|
0 | usd | |
CY2022Q3 | us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
0 | usd |
CY2021Q3 | us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
0 | usd |
us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
-34306 | usd | |
us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
0 | usd | |
CY2022Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
18494 | usd |
CY2021Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
3114 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-27065 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
29444 | usd | |
CY2022Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-969696 | usd |
CY2021Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-575772 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-2982996 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1135925 | usd | |
CY2022Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2021Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-969696 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-575772 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2982996 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-1135925 | usd | |
CY2022Q3 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
48457 | usd |
CY2021Q3 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
33875 | usd |
us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
137305 | usd | |
us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
65662 | usd | |
CY2022Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1018153 | usd |
CY2021Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-609647 | usd |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-3120301 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1201587 | usd | |
CY2022Q3 | onfo |
Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
|
-0.31 | |
CY2021Q3 | onfo |
Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
|
-0.30 | |
onfo |
Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
|
-1.17 | ||
onfo |
Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
|
-0.59 | ||
CY2022Q3 | onfo |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
3284339 | shares |
CY2021Q3 | onfo |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
2018003 | shares |
onfo |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
2675634 | shares | |
onfo |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
2022267 | shares | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3373805 | usd |
CY2022Q1 | onfo |
Preferred Shares For Cash Amount
PreferredSharesForCashAmount
|
130000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
219660 | usd |
CY2022Q1 | onfo |
Preferred Dividends
PreferredDividends
|
-43120 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-748766 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2931579 | usd |
CY2022Q2 | onfo |
Preferred Shares For Cash Amount
PreferredSharesForCashAmount
|
186500 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
240185 | usd |
CY2022Q2 | onfo |
Preferred Dividends
PreferredDividends
|
-45728 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1264534 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2048002 | usd |
CY2022Q3 | onfo |
Preferred Shares For Cash Amount
PreferredSharesForCashAmount
|
5000 | usd |
CY2022Q3 | onfo |
Common Stock Issued Initial Public Offering Amount
CommonStockIssuedInitialPublicOfferingAmount
|
12255470 | usd |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
247706 | usd |
CY2022Q3 | onfo |
Preferred Dividends
PreferredDividends
|
-48457 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-969696 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-575772 | usd |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1187748 | usd |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1868653 | usd |
CY2021Q1 | onfo |
Preferred Shares For Cash Amount
PreferredSharesForCashAmount
|
512000 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
191662 | usd |
CY2021Q1 | onfo |
Common Shares For Cash Amount
CommonSharesForCashAmount
|
10000 | usd |
CY2021Q1 | onfo |
Preferred Dividends
PreferredDividends
|
-13637 | usd |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-155852 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1731921 | usd |
CY2021Q2 | onfo |
Preferred Shares For Cash Amount
PreferredSharesForCashAmount
|
453000 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
191666 | usd |
CY2021Q2 | onfo |
Preferred Dividends
PreferredDividends
|
-18150 | usd |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-404301 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1954136 | usd |
CY2021Q3 | onfo |
Preferred Shares For Cash Amount
PreferredSharesForCashAmount
|
305000 | usd |
CY2021Q3 | onfo |
Common Shares For Cash Amount
CommonSharesForCashAmount
|
27500 | usd |
CY2021Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
191664 | usd |
CY2021Q3 | onfo |
Preferred Dividends
PreferredDividends
|
-33875 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-2982996 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-1135925 | usd | |
us-gaap |
Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
707551 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
574992 | usd | |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-26056 | usd | |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-40127 | usd | |
us-gaap |
Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
|
23915 | usd | |
us-gaap |
Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
|
17900 | usd | |
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
34306 | usd | |
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
4491 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-29220 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-4058 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-18933 | usd | |
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
120214 | usd | |
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
6386 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
39163 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
91508 | usd | |
onfo |
Increase Decrease In Due To Joint Ventures
IncreaseDecreaseInDueToJointVentures
|
-26561 | usd | |
onfo |
Increase Decrease In Due To Joint Ventures
IncreaseDecreaseInDueToJointVentures
|
-7099 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-21802 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1492 | usd | |
us-gaap |
Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
|
-480 | usd | |
us-gaap |
Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
|
-1410 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2373607 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-459886 | usd | |
us-gaap |
Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
|
45694 | usd | |
us-gaap |
Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
|
75000 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
0 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
784000 | usd | |
onfo |
Advances To Related Parties
AdvancesToRelatedParties
|
0 | usd | |
onfo |
Advances To Related Parties
AdvancesToRelatedParties
|
2345 | usd | |
onfo |
Investments In Joint Ventures
InvestmentsInJointVentures
|
22500 | usd | |
onfo |
Investments In Joint Ventures
InvestmentsInJointVentures
|
0 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
23194 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-711345 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
12255470 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
37500 | usd | |
onfo |
Proceeds From Sale Of Series A Preferred Stock
ProceedsFromSaleOfSeriesAPreferredStock
|
321500 | usd | |
onfo |
Proceeds From Sale Of Series A Preferred Stock
ProceedsFromSaleOfSeriesAPreferredStock
|
1270000 | usd | |
us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
91264 | usd | |
us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
32978 | usd | |
onfo |
Payment Of Contribution To Joint Venture
PaymentOfContributionToJointVenture
|
-215000 | usd | |
onfo |
Payment Of Contribution To Joint Venture
PaymentOfContributionToJointVenture
|
-45000 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
171170 | usd | |
onfo |
Payments From Note Payables
PaymentsFromNotePayables
|
-59228 | usd | |
onfo |
Payments From Note Payables
PaymentsFromNotePayables
|
-53316 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
44000 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
108000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12255478 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1113036 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
9905065 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-58195 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1710318 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
521709 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11615383 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
463514 | usd |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd | |
us-gaap |
Interest Paid
InterestPaid
|
5493 | usd | |
us-gaap |
Interest Paid
InterestPaid
|
14719 | usd | |
CY2022Q3 | onfo |
Description Of Dominic Wells
DescriptionOfDominicWells
|
the Company issued 2,000,000 shares to Dominic Wells, the Company’s CEO in exchange for 100% of the membership interest of Onfolio LLC | |
onfo |
Investment In Unconsolidated Entities Equity And Cost Method Investments Policytextblock
InvestmentInUnconsolidatedEntitiesEquityAndCostMethodInvestmentsPolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We account for our interests in entities in which we are able to exercise significant influence over operating and financial policies, generally 50% or less ownership interest, under the equity method of accounting. In such cases, our original investments are recorded at cost and adjusted for our share of earnings, losses and distributions. We account for our interests in entities where we have virtually no influence over operating and financial policies under the cost method of accounting. In such cases, our original investments are recorded at the cost to acquire the interest and any distributions received are recorded as income. Our investments in Onfolio JV I, LLC (“JV I”), Onfolio JV II, LLC (“JV II”) and Onfolio JV III, LLC (“JV III”) are accounted for under the cost method. All investments are subject to our impairment review policy. The Company recognized the value of its investments in these joint ventures at carryover basis based on the amount paid by the CEO to the joint venture for Onfolio JV 1 LLC, and agreed to pay the joint venture the contribution for Onfolio JV II LLC and Onfolio JV III LLC at the carryover basis for the amount the interest was acquired for by the CEO.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The current investment in unconsolidated affiliates accounted for under the equity method consists of a 35.8% interest in Onfolio JV IV, LLC (“JV IV”), which is involved in the acquisition, development and operation of websites to produce adverting revenue. The initial value of an investment in an unconsolidated affiliate accounted for under the equity method is recorded at the fair value of the consideration paid.</p> | ||
us-gaap |
Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
|
0.50 | pure | |
us-gaap |
Investment Company Total Return Payment To Fund By Affiliate
InvestmentCompanyTotalReturnPaymentToFundByAffiliate
|
0.358 | pure | |
onfo |
Long Lived Assets Policytextblock
LongLivedAssetsPolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company amortizes acquired definite-lived intangible assets over their estimated useful lives. Other indefinite-lived intangible assets are not amortized but subject to annual impairment tests. In accordance with ASC 360 “Property Plant and Equipment,” the Company reviews the carrying value of intangibles subject to amortization and long-lived assets for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Recoverability of long-lived assets is measured by comparison of its carrying amount to the undiscounted cash flows that the asset or asset group is expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the property, if any, exceeds its fair market value.</p> | ||
CY2022Q3 | us-gaap |
Management Fee Expense
ManagementFeeExpense
|
68155 | usd |
CY2021Q3 | us-gaap |
Management Fee Expense
ManagementFeeExpense
|
66887 | usd |
us-gaap |
Management Fee Expense
ManagementFeeExpense
|
257325 | usd | |
us-gaap |
Management Fee Expense
ManagementFeeExpense
|
245618 | usd | |
CY2022Q3 | us-gaap |
Advertising Expense
AdvertisingExpense
|
12615 | usd |
CY2021Q3 | us-gaap |
Advertising Expense
AdvertisingExpense
|
55290 | usd |
us-gaap |
Advertising Expense
AdvertisingExpense
|
68359 | usd | |
us-gaap |
Advertising Expense
AdvertisingExpense
|
159401 | usd | |
CY2022Q3 | us-gaap |
Production Costs
ProductionCosts
|
191525 | usd |
CY2021Q3 | us-gaap |
Production Costs
ProductionCosts
|
131815 | usd |
us-gaap |
Production Costs
ProductionCosts
|
464735 | usd | |
us-gaap |
Production Costs
ProductionCosts
|
463248 | usd | |
CY2022Q3 | us-gaap |
Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
|
80006 | usd |
CY2021Q3 | us-gaap |
Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
|
136431 | usd |
us-gaap |
Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
|
305627 | usd | |
us-gaap |
Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
|
506356 | usd | |
CY2022Q3 | us-gaap |
Revenues
Revenues
|
352301 | usd |
CY2021Q3 | us-gaap |
Revenues
Revenues
|
390423 | usd |
us-gaap |
Revenues
Revenues
|
1096046 | usd | |
us-gaap |
Revenues
Revenues
|
1374623 | usd | |
CY2022Q3 | us-gaap |
Investment Company Total Return
InvestmentCompanyTotalReturn
|
0.10 | pure |
onfo |
Cost Of Revenue Policytextblock
CostOfRevenuePolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cost of product revenue consists primarily of costs associated with the acquisition and shipment of products being sold through the Company’s online marketplaces, and the costs of its service revenue, which include website content creation costs including contract labor, domain and hosting costs and certain software costs related to website operations.</p> | ||
us-gaap |
Effective Income Tax Rate Reconciliation Beat Percent
EffectiveIncomeTaxRateReconciliationBeatPercent
|
0.50 | pure | |
us-gaap |
Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
|
0.15 | pure | |
onfo |
Expected Dividendspolicytextblock
ExpectedDividendspolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Expected Dividends. - </span>We have never declared or paid any cash dividends on any of our capital stock and do <em>not</em> expect to do so in the foreseeable future. Accordingly, we use an expected dividend yield of zero to calculate the grant-date fair value of a stock option.</p> | ||
onfo |
Expected Volatilitypolicytextblock
ExpectedVolatilitypolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Expected Volatility. - </span>The expected volatility is a measure of the amount by which our stock price is expected to fluctuate during the expected term of options granted. We determine the expected volatility solely based upon the historical volatility of a peer group of companies of similar size and with similar operations.</p> | ||
onfo |
Risk Free Interest Ratepolicytextblock
RiskFreeInterestRatepolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Risk-Free Interest Rate. </span> - The risk-free interest rate is the implied yield available on U.S. Treasury <em>zero</em>-coupon issues with a remaining term equal to the option’s expected term on the grant date.</p> | ||
onfo |
Expected Termpolicytextblock
ExpectedTermpolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Expected Term. </span>The expected life of stock options granted is based on the actual vesting date and the end of the contractual term.</p> | ||
onfo |
Stock Option Exercise Price And Grant Date Price Of Common Stockpolicytextblock
StockOptionExercisePriceAndGrantDatePriceOfCommonStockpolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Stock Option Exercise Price and Grant Date Price of Common Stock. -</span> Currently the Company utilizes the most recent cash sale price of its common stock as the most reasonable indication of fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for compensation cost for stock option plans and for share based payments to non-employees in accordance with ASC 505, “Accounting for Equity Instruments Issued to Non-Employees for Acquiring, or in Conjunction with Selling, Goods or Services“. Share-based awards to non-employees are expensed over the period in which the related services are rendered at their fair value.</p> | ||
CY2022Q3 | onfo |
Revenue In Joint Venture
RevenueInJointVenture
|
28008 | usd |
CY2021Q3 | onfo |
Revenue In Joint Venture
RevenueInJointVenture
|
36572 | usd |
onfo |
Revenue In Joint Venture
RevenueInJointVenture
|
81777 | usd | |
onfo |
Revenue In Joint Venture
RevenueInJointVenture
|
120640 | usd | |
CY2022Q3 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
26740 | usd |
CY2021Q3 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
35204 | usd |
us-gaap |
Net Investment Income
NetInvestmentIncome
|
69115 | usd | |
us-gaap |
Net Investment Income
NetInvestmentIncome
|
112087 | usd | |
CY2019Q4 | us-gaap |
Acquisition Costs
AcquisitionCosts
|
260937 | usd |
CY2020Q4 | us-gaap |
Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
|
297323 | usd |
CY2021Q4 | onfo |
Intangible Assets Cash Paid
IntangibleAssetsCashPaid
|
200000 | usd |
CY2021Q4 | us-gaap |
Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
|
17323 | usd |
CY2020Q4 | onfo |
Llc Subsidiary Formation Price
LlcSubsidiaryFormationPrice
|
120000 | usd |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
121000 | usd |
CY2022Q1 | onfo |
Cash Paid At Closing Of The Transaction
CashPaidAtClosingOfTheTransaction
|
11000 | usd |
CY2021Q4 | onfo |
Cash Paid At Closing Of The Transaction
CashPaidAtClosingOfTheTransaction
|
110000 | usd |
CY2021Q1 | onfo |
Selling Intellectual Property
SellingIntellectualProperty
|
700000 | usd |
CY2021Q1 | us-gaap |
Management Fee Payable
ManagementFeePayable
|
42000 | usd |
CY2021Q2 | onfo |
Selling Intellectual Property
SellingIntellectualProperty
|
75000 | usd |
CY2021Q3 | onfo |
Selling Intellectual Property
SellingIntellectualProperty
|
84000 | usd |
CY2022Q2 | onfo |
Selling Intellectual Property
SellingIntellectualProperty
|
45694 | usd |
CY2022Q2 | us-gaap |
Disposal Group Deferred Gain On Disposal
DisposalGroupDeferredGainOnDisposal
|
34306 | usd |
us-gaap |
Related Party Costs
RelatedPartyCosts
|
7392 | usd | |
CY2022Q3 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
1308260 | usd |
CY2021Q4 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
1388260 | usd |
CY2022Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | onfo |
Series A Preferred Stock Shares Designated
SeriesAPreferredStockSharesDesignated
|
1000000 | shares |
CY2021Q4 | us-gaap |
Proceeds From Customers
ProceedsFromCustomers
|
1415000 | usd |
us-gaap |
Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
|
12860 | shares | |
us-gaap |
Proceeds From Customers
ProceedsFromCustomers
|
321500 | usd | |
us-gaap |
Dividends
Dividends
|
137305 | usd | |
us-gaap |
Dividends
Dividends
|
65662 | usd | |
us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
91264 | usd | |
us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
32978 | usd | |
CY2022Q3 | onfo |
Unpaid Dividends
UnpaidDividends
|
47539 | usd |
CY2021Q4 | onfo |
Unpaid Dividends
UnpaidDividends
|
1498 | usd |
CY2022Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
69660 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
56800 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
413063 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
826126 | usd | |
onfo |
Description Of Additional Warrants
DescriptionOfAdditionalWarrants
|
On August 29, 2022, the underwriter partially exercised this option and purchased 609,750 additional warrants at the purchase price of $.01 per warrant for aggregate gross proceeds of $6,097.50 | ||
us-gaap |
Key Provisions Of Operating Or Partnership Agreement Description
KeyProvisionsOfOperatingOrPartnershipAgreementDescription
|
Pursuant to the underwriting agreement, the Company sold 2,753,750 units at a public offering price of $5.00 per unit, with each unit consisting of one share of common stock, par value $0.001 per share , and two warrants, with each warrant exercisable to purchase one share of common stock, at an exercise price of $5.00 per share | ||
onfo |
Share Based Compensation1
ShareBasedCompensation1
|
95890 | usd | |
us-gaap |
Officers Compensation
OfficersCompensation
|
194170 | usd | |
us-gaap |
Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
|
82613 | usd | |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
550000 | usd | |
us-gaap |
Public Utilities Interim Rate Increase Decrease Percentage
PublicUtilitiesInterimRateIncreaseDecreasePercentage
|
1.10 | pure | |
us-gaap |
Common Stock Dividends Shares
CommonStockDividendsShares
|
2753750 | shares | |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
5507500 | usd | |
CY2022Q3 | us-gaap |
Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
|
13774848 | usd |
CY2022Q3 | us-gaap |
Proceeds From Other Equity
ProceedsFromOtherEquity
|
12225470 | usd |
onfo |
Common Stock Warrant Informationtabletextblock
CommonStockWarrantInformationtabletextblock
|
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Awards</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Grant Date Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Outstanding at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,199,863</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.21</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.01</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Forfeited and cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Outstanding at September 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">6,199,863</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4.21</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">5.01</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exercisable at September 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">6,117,250</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4.21</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">5.00</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> | ||
us-gaap |
Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
|
P4Y10M24D | ||
us-gaap |
Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
|
1.23 | pure | |
us-gaap |
Policyholder Dividends Rate On Policy Earnings
PolicyholderDividendsRateOnPolicyEarnings
|
0 | pure | |
CY2020Q4 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
3233336 | usd |
CY2020Q4 | us-gaap |
Dividends Share Based Compensation
DividendsShareBasedCompensation
|
670882 | usd |
CY2022Q3 | us-gaap |
Deferred Compensation Equity
DeferredCompensationEquity
|
638912 | usd |
us-gaap |
Restricted Stock Award Forfeitures Dividends
RestrictedStockAwardForfeituresDividends
|
2800 | usd | |
us-gaap |
Dividends Share Based Compensation
DividendsShareBasedCompensation
|
20000 | usd | |
onfo |
Shares Issued Worth Of Shares Per To Director Value
SharesIssuedWorthOfSharesPerToDirectorValue
|
5000 | usd | |
onfo |
Cash Issued To Director
CashIssuedToDirector
|
2500 | usd | |
CY2022Q3 | onfo |
Accrued Cash Compensation
AccruedCashCompensation
|
30000 | usd |
us-gaap |
Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
|
49560 | shares | |
us-gaap |
Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
|
23100 | shares | |
us-gaap |
Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
|
363000 | usd | |
onfo |
Description Of Black Scholes Option Pricing Model
DescriptionOfBlackScholesOptionPricingModel
|
1) dividend yield of 0%; 2) risk-free rate of 0.97% to 1.91%; 3) volatility of 127.7% to 129.5% based on a group of peer group companies; 4) a common stock price of $5.95 based on the most recent common stock sales for cash, and 5) an expected term of three years | ||
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2100 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
5.95 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
72660 | shares | |
onfo |
Weighted Average Grant Date Fair Value Granted
WeightedAverageGrantDateFairValueGranted
|
4.16 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
9.00 | ||
onfo |
Weighted Average Grant Date Fair Value Exercised
WeightedAverageGrantDateFairValueExercised
|
0 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
4515 | shares | |
onfo |
Weighted Average Grant Date Fair Value Forfeited And Cancelled
WeightedAverageGrantDateFairValueForfeitedAndCancelled
|
-4.36 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
5.95 | ||
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
70245 | shares |
CY2022Q3 | onfo |
Weighted Average Grant Date Fair Valueending
WeightedAverageGrantDateFairValueending
|
4.15 | |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
8.69 | |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
22590 | shares |
CY2022Q3 | onfo |
Weighted Average Grant Date Fair Valueexercisable
WeightedAverageGrantDateFairValueexercisable
|
4.22 | |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
7.97 | |
us-gaap |
Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1
NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1
|
P2Y4M20D | ||
CY2022Q3 | onfo |
Due From Related Parties Included In Current Assets
DueFromRelatedPartiesIncludedInCurrentAssets
|
35561 | usd |
CY2022Q3 | onfo |
Due From Related Parties Included In Current Liabilities
DueFromRelatedPartiesIncludedInCurrentLiabilities
|
16 | usd |
CY2021Q4 | onfo |
Due To Related Parties Included In Current Liabilities
DueToRelatedPartiesIncludedInCurrentLiabilities
|
50894 | usd |
CY2021Q4 | us-gaap |
Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
|
155000 | usd |
CY2021Q4 | us-gaap |
Due From Joint Ventures Current
DueFromJointVenturesCurrent
|
60000 | usd |
CY2021Q1 | us-gaap |
Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
|
54240 | usd |
CY2021Q1 | us-gaap |
Cash
Cash
|
48000 | usd |
CY2021Q1 | us-gaap |
Public Utilities Approved Rate Increase Decrease Percentage
PublicUtilitiesApprovedRateIncreaseDecreasePercentage
|
0.17 | pure |
CY2021Q3 | us-gaap |
Short Term Investments
ShortTermInvestments
|
66600 | usd |
CY2021Q3 | us-gaap |
Cash
Cash
|
60000 | usd |
CY2022Q1 | onfo |
Company Owed
CompanyOwed
|
6659 | usd |
CY2021Q1 | onfo |
Company Owed
CompanyOwed
|
28513 | usd |
CY2022Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
47520 | usd |
CY2022Q2 | us-gaap |
Cash
Cash
|
44000 | usd |
CY2022Q3 | onfo |
Company Owed
CompanyOwed
|
13286 | usd |